Featured News
SDRC News
More News
SDRC Investigator Natalie Torok Unveils New Insights on Liver Cancer Risk in Type 2 Diabetes Patients
A Stanford Medicine study led by Natalie Torok suggests revised screening guidelines, highlighting viscoelasticity as a key biophysical marker for liver cancer in diabetics, challenging traditional approaches to diagnosis.
SDRC Investigators Michael Snyder and Tracey McLaughlin Harness AI to Predict and Identify Type 2 Diabetes Subtypes Using Simple Glucose Monitors
New AI-powered algorithm offers a more accurate, accessible method for diagnosing diabetes subtypes and tailoring treatments, with potential for widespread impact.
Breakthrough Study by SDRC Investigator Jonathan Long Uncovers the Connection Between PTER and Taurine Metabolism in the Fight Against Obesity
Jonathan Long's team has uncovered a link between PTER and taurine metabolism in mice, revealing its potential to combat weight gain and metabolic disorders thus paving the way for innovative anti-obesity drugs through a novel GLP1R-independent pathway.
SDRC Investigator Jonathan Long Co-Discovers Lac-Phe: Molecule Produced After Exercise, Also Linked to Metformin-Induced Moderate Weight Loss
Metformin and Sprint Exercise Affect Your Body Weight through the Same Pathway.
Stanford Medicine endocrinologist Sun H. Kim, MD, MS, and bariatric surgeon Dan Azagury, MD, FACS, break down how GLP-1 medications work, who may benefit, and why they're not a one-size-fits-all solution. [Watch the video →]. Read full Article here.